STRS Ohio’s Tonix Pharmaceuticals TNXP Stock Holding History

STRS Ohio’s Portfolio TNXP Stock Details TNXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$10.7K	Buy	+1,100	New	+$13K	﹤0.01%	2183
2026 Q1	–	Sell	-7,800	Closed	-$122K	–	2219
2025 Q4	$122K	Buy	7,800 +700	+10%	+$12.9K	﹤0.01%	1752
2025 Q3	$172K	Buy	7,100 +4,300	+154%	+$160K	﹤0.01%	1610
2025 Q2	$101K	Buy	+2,800	New	+$73.4K	﹤0.01%	1857
2022 Q2	–	Hold	0	–	-$17K	–	2287
2022 Q1	–	Hold	0	–	–	–	2062
2021 Q4	–	Hold	0	–	–	–	2084
2021 Q3	–	Hold	0	–	–	–	2087
2021 Q2	–	Hold	0	–	–	–	2013

Other funds holding TNXP

Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return

Acorn Wealth Advisors Grand Blanc, Michigan $407M AUM 14.44% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

CNBT

Cornerstone National Bank & Trust Palatine, Illinois $309M AUM 7.69% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

SJS Investment Consulting Sylvania, Ohio $993M AUM 16.29% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

STRS Ohio's TNXP Position: Q3 2026 in Review

STRS Ohio opened a new position in Tonix Pharmaceuticals (TNXP) in Q3 2026: 1,100 shares worth $10.7K. The stake represents ﹤0.01% of the portfolio and ranks #2183 among its holdings. This is a return to the name: STRS Ohio previously reported a position in TNXP as recently as Q4 2025.

STRS Ohio first reported a position in TNXP in Q2 2025 and has held it in 4 quarters since. The position peaked at $172K in Q3 2025. 22 funds tracked by Wall St. Rank hold TNXP as of Q3 2026.

STRS Ohio held 1,100 shares of Tonix Pharmaceuticals worth $10.7K as of Q3 2026.
Tonix Pharmaceuticals was a new STRS Ohio position in Q3 2026.
Tonix Pharmaceuticals made up ﹤0.01% of STRS Ohio's portfolio in Q3 2026, its #2183 holding.
STRS Ohio first reported a position in Tonix Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
STRS Ohio's Tonix Pharmaceuticals position peaked at $172K in Q3 2025.
22 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q3 2026.

Based on STRS Ohio's 13F filing for Q3 2026, filed 30 Oct 2026.